PARSCHAUER KARAH HERDMAN (EVP and Chief Legal Officer) sold 12.5% of their position (9.53K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $208.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/10/2026ACC: 0001193125-26-100309
Officer· EVP and Chief Legal Officer
Since Mar 2026
-9.53K
Net shares
Net seller
$208.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.02K
Price / share
$21.40
Trade value
$128.79K
% of position
7.9%
3/6/2026
76.35K→70.33K
Common Stock
Direct
Shares
−3.51K
Price / share
$22.67
Trade value
$79.53K
% of position
5.0%
3/10/2026
70.33K→66.82K
Total
Net shares
−9.53K
Net value
-$208.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | S · Sale | −6.02K | $21.40 | $128.79K | 7.9% | 76.35K | 70.33K |
| Common Stock Direct | 3/10/2026 | S · Sale | −3.51K | $22.67 | $79.53K | 5.0% | 70.33K | 66.82K |
| Total | −9.53K | -$208.31K | ||||||
Derivative Transactions0
No derivative transactions reported